The generic pharmaceutical industry stands at a pivotal crossroads where innovation in manufacturing processes and formulation technologies is reshaping traditional […]

Successfully challenging a drug patent requires strategic legal, regulatory, and technical approaches to overcome brand-name manufacturers’ defenses. Here are the

The pharmaceutical industry operates at the nexus of scientific innovation, stringent regulation, and substantial financial investment. At the core of

When pharmaceutical patents expire, they create a feeding frenzy in financial markets akin to “blood in the water,” as investors

To optimize regulatory submissions for multi-market generic drug approvals, companies must adopt strategic approaches that align with diverse regulatory requirements

Pharmaceutical patent thickets—dense webs of overlapping patents on single drugs—represent a systemic abuse of intellectual property protections that prioritizes corporate

Multidistrict litigation (MDL) in Paragraph IV patent cases presents unique strategic opportunities and challenges for both brand-name pharmaceutical companies and